Nutra Pharma Corp.
NPHCOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1431945
P/E Ratio—
52W High$0.005
52W Low$0.0001
Nutra Pharma Corp. (NPHC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NPHC · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2022Report Date: Sep 30, 2022EPS Actual
$0.00
Revenue
$0.00B
Fiscal Period
Q3 FY2022
FY ends December
Report Date
Sep 30, 2022
After Market Close
NPHC reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2025 | Oct 23, 2025 | — | — | — | — | — | — |
| — Q3 FY2022 | Sep 30, 2022 | — | $0.00 | — | $0.00B | — | — |
| — Q3 FY2022 | Aug 22, 2022 | — | -$0.00 | — | $0.00B | — | — |
| — Q1 FY2022 | Mar 31, 2022 | — | $0.00 | — | $0.00B | — | — |
| — Q4 FY2021 | Dec 31, 2021 | — | $0.00 | — | $0.00B | — | — |
| — Q4 FY2021 | Nov 10, 2021 | — | $0.00 | — | $0.00B | — | — |
| — Q2 FY2021 | Jun 30, 2021 | — | $0.00 | — | $0.00B | — | — |
| — Q1 FY2021 | Mar 31, 2021 | — | -$0.00 | — | $0.00B | — | — |
Q4 FY2025
Oct 23, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2022
Sep 30, 2022
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2022
Aug 22, 2022
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2022
Mar 31, 2022
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2021
Dec 31, 2021
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2021
Nov 10, 2021
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2021
Jun 30, 2021
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2021
Mar 31, 2021
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 1 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 1 |
| Q2 FY2023 | $1.19 | $1.19 | $1.19 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2022 | Sep 30, 2022 | — | $0.00 | $0.00 | +0.00% |
| — Q3 FY2022 | Aug 22, 2022 | — | $0.00 | $0.00 | +0.00% |
| — Q1 FY2022 | Mar 31, 2022 | — | $0.00 | $0.00 | -26.67% |
| — Q4 FY2021 | Dec 31, 2021 | — | $0.00 | $0.00 | +11.11% |
| — Q4 FY2021 | Nov 10, 2021 | — | $0.00 | $0.00 | +10.00% |
| — Q2 FY2021 | Jun 30, 2021 | — | $0.01 | $0.01 | -2.99% |
| — Q1 FY2021 | Mar 31, 2021 | — | $0.01 | $0.01 | +5.19% |
| — Q4 FY2020 | Dec 31, 2020 | — | $0.00 | $0.00 | +0.00% |
Q3 FY2022+0.00%
Report Date
Sep 30, 2022
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q3 FY2022+0.00%
Report Date
Aug 22, 2022
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q1 FY2022-26.67%
Report Date
Mar 31, 2022
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q4 FY2021+11.11%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q4 FY2021+10.00%
Report Date
Nov 10, 2021
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q2 FY2021-2.99%
Report Date
Jun 30, 2021
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q1 FY2021+5.19%
Report Date
Mar 31, 2021
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q4 FY2020+0.00%
Report Date
Dec 31, 2020
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Beat Rate0 / 8 quarters
Largest Move-26.67% (Q1 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NPHC ends December
Nutra Pharma Corp. (NPHC) most recently reported earnings on September 30, 2022 for Q3 FY2022, posting EPS of $0.00 (in line with the analyst consensus of —). The next NPHC earnings date is expected around September 1, 2026.
Each quarter, investors track NPHC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NPHC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NPHC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NPHC earnings · 4 questionsNutra Pharma Corp.'s next earnings report is expected around September 1, 2026. NPHC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NPHC historically reports after market close (AMC).
NPHC earnings datewhen is NPHC earningsNPHC next earnings datewhen does NPHC report earningsNPHC earnings calendar
▸ Source: FMP · Nutra Pharma Corp. SEC filings · US GAAP · Nutra Pharma Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026